Tagged with R

ISU Abxis: Charting a New Direction
Korea’s Medicine Man
The Three Top Political Issues for Big Pharma
AI: The Time is Right for a New Pharma Business Model
Chi Steve Chan – Chairman & CEO, Adimmune Corporation, Taiwan
Olav Fromm – Managing Director, Chiesi Nordics
Nick Lee – General Manager, Ipsen Taiwan, Hong Kong & Macau
Jennifer Hawks Bland – CEO, NewYorkBIO, USA
Jenny Chao – Founder & CEO and Aries Chang – Laboratory Manager, BiotechTS, Taiwan
Fabian Bieletzki – General Manager, Kirsch Pharma China
Sheron Lin – President, Daiichi Sankyo Taiwan
Lucy Crespo – CEO, Puerto Rico Science, Technology & Research Trust (PRSTRT)
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here